STORY FROM: Drugs & Medical Devices

OxyContin Time-Release Feature Flawed, Lawsuit Alleges

TRENTON, N.J. - A class action lawsuit was filed on behalf of all New Jersey residents who have been prescribed and have ingested OxyContin from 1995 to the present, alleging that OxyContin's controlled time-release feature was flawed and that drugmakers Purdue Pharma and Abbott Laboratories concealed their knowledge of the flaw. Devoe v. P.F. Laboratories, Inc., et al., No. n/a (N.J. Super. Ct., Mercer Cty.).

The Feb. 26 complaint, as well as a similar lawsuit filed in Washington D.C., alleges that the defendants significantly downplayed the addiction risks of OxyContin and seeks refunds or reimbursements for patients who obtained the ...

Associated Documents
Complaint



Registered User Login

Username

Password

True